Page 784 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

762 PART IV Specific Malignancies in the Small Animal Patient

408. Matus RE, Leifer CE, MacEwen EG: Acute lymphoblastic leuke- 432. Rissetto KVJ, Selting KA, et al.: Recent trends in feline intesti-
mia in the dog: a review of 30 cases, J Am Vet Med Assoc 183:859– nal neoplasia: an epidemiologic study of 1,129 cases in the veteri-
862, 1983. nary medicanl database from 1964 to 2004, J Am Anim Hosp Assoc
VetBooks.ir 409. Adams J, Mellanby RJ, Villiers E, et al.: Acute B cell lymphoblas- 433. Schmidt JM, North SM, Freeman KP, et al.: Feline paediatric
47:28–36, 2011.
tic leukaemia in a 12-week-old greyhound, J Small Anim Pract
45:553–557, 2004.
410. Hodgkins EM, Zinkl JG, Madewell BR: Chronic lymphocytic leu- oncology: retrospective assessment of 233 tumours from cats up to
one year (1993 to 2008), J Small Anim Pract 51:306–311, 2010.
kemia in the dog, J Am Vet Med Assoc 177:704–707, 1980. 434. Gabor LJ, Malik R, Canfield PJ: Clinical and anatomical features of
411. Comazzi S, Aresu L, Marconato L: Transformation of canine lym- lymphosarcoma in 118 cats, Aust Vet J 76:725–732, 1998.
phoma/leukemia to more aggressive diseases: anecdotes or reality? 435. Gabor LJ, Canfield PJ, Malik R: Immunophenotypic and histo-
Front Vet Sci 2(42), 2015. logical characterisation of 109 cases of feline lymphosarcoma, Aust
412. Comazzi S, Martini V, Riondato F, et al.: Chronic lymphocytic leu- Vet J 77:436–441, 1999.
kemia transformation into high-grade lymphoma: a description of 436. Barrs VR, Beatty JA: Feline alimentary lymphoma: 1. Classifi-
Richter’s syndrome in eight dogs, Vet Comp Oncol 15:366–373, 2017. cation, risk factors, clinical signs and non-invasive diagnostics,
413. Januszewicz E, Cooper IA, Pilkington G, et al.: Blastic transforma- J Feline Med Surg 14:182–190, 2012.
tion of chronic lymphocytic leukemia, Am J Hematol 15:399–402, 437. Crouse Z, Phillips B, Flory A, et al.: Post-chemotherapy perfora-
1983. tion in cats with discrete intermediate- or large-cell gastrointestinal
414. Harvey JW, Terrell TG, Hyde DM, et al.: Well-differentiated lym- lymphoma, J Feline Med Surg, 2017. https://doi.org/10.1177/1098
phocytic leukemia in a dog: long-term survival without therapy, Vet 612X17723773. epub ahead of print.
Pathol 18:37–47, 1981. 438. Finotello R, Vasconi ME, Sabattini S, et al.: Feline large granular
415. Boyce KL, Kitchell BE: Treatment of canine lymphoma with lymphocyte lymphoma: an Italian Society of Veterinary Oncology
COPLA/LVP, J Am Anim Hosp Assoc 36:395–403, 2000. (SIONCOV) retrospective study, Vet Comp Oncol 16:159–166,
416. Sato M, Yamazaki J, Goto-Koshino Y, et al.: Increase in minimal 2018.
residual disease in peripheral blood before clinical relapse in dogs 439. Gustafson TL, Villamil A, Taylor BE, et al.: A retrospective study
with lymphoma that achieved complete remission after chemother- of feline gastric lymphoma in 16 chemotherapy-treated cats, J Am
apy, J Vet Intern Med 25:292–296, 2011. Anim Hosp Assoc 50:46–52, 2014.
417. Gentilini F, Calzolari C, Turba ME, et al.: Prognostic value of serum 440. Rau SE, Burgess KE: A retrospective evaluation of lomustine
vascular endothelial growth factor (VEGF) and plasma activity of (CeeNU) in 32 treatment naive cats with intermediate to large
matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected cell gastrointestinal lymphoma (2006-2013), Vet Comp Oncol
dogs, Leuk Res 29:1263–1269, 2005. 15:1019–1028, 2017.
418. Hahn KA, Barnhill MA, Freeman KP, et al.: Detection and clini- 441. Sabattini S, Bottero E, Turba ME, et al.: Differentiating feline
cal significance of plasma glutathione-S-transferases in dogs with inflammatory bowel disease from alimentary lymphoma in duode-
lymphoma, In Vivo 13:173–175, 1999. nal endoscopic biopsies, J Small Anim Pract 57:396–401, 2016.
419. Heath 3rd H, Weller RE, Mundy GR: Canine lymphosarcoma: a 442. Ahmad S, Levy LS: The frequency of occurrence and nature of
model for study of the hypercalcemia of cancer, Calcif Tissue Int recombinant feline leukemia viruses in the induction of multicen-
30:127–133, 1980. tric lymphoma by infection of the domestic cat with FeLV-945,
420. weller RHC, Theilen GH, et al.: Canine lymphosarcoma and Virology 403:103–110, 2010.
hypercalcemia: clinical laboratory and pathologic evaluation of 443. Fuhino YSH, Ohno K, et al.: Molecular cytogenetic analysis of
twenty-four cases, J Small Anim Pract 23:649–658, 1982. feline leukemia virus insertions in cat lymphoid tumor cells, J Virol
421. Couto CG: Oncology. In R.G.S., editor: The cat: diseases and clini- Methods 163:344–352, 2010.
cal management, New York, 1989, Churchill Livingstone. 444. Stutzer B, Simon K, Lutz H, et al.: Incidence of persistent viraemia
422. Hardy WJ: Hematopoietic tumors of cats, J Am Anim Hosp Assoc and latent feline leukaemia virus infection in cats with lymphoma,
17:921–940, 1981. J Feline Med Surg 13:81–87, 2011.
423. Essex MFD: The risk to humans from malignant diseases of their 445. Fujino Y, Liao CP, Zhao YS, et al.: Identification of a novel common
pets: an unsettled issue, J Am Anim Hosp Assoc 12:386–390, 1976. proviral integration site, flit-1, in feline leukemia virus induced thy-
424. Theillen G, Madewell BR: Feline hematopoietic neoplasms. In mic lymphoma, Virology 386:16–22, 2009.
Theilen GHMB, editor: Veterinary cancer medicine, ed 2, Philadel- 446. Fujino Y, Ohno K, Tsujimoto H: Molecular pathogenesis of feline
phia, 1987, Lea & Febiger. leukemia virus-induced malignancies: insertional mutagenesis, Vet
425. Beatty J: Viral causes of feline lymphoma: retroviruses and beyond, Immunol Immunopathol 123:138–143, 2008.
Vet J 201:174–180, 2014. 447. Weiss AT, Klopfleisch R, Gruber AD: Prevalence of feline leukae-
426. Meichner K, Kruse DB, Hirschberger J, et al.: Changes in preva- mia provirus DNA in feline lymphomas, J Feline Med Surg 12:929–
lence of progressive feline leukaemia virus infection in cats with 935, 2010.
lymphoma in Germany, Vet Rec 171:348, 2012. 448. Beatty JA, Lawrence CE, Callanan JJ, et al.: Feline immunode-
427. Louwerens M, London CA, Pedersen NC, et al.: Feline lymphoma in ficiency virus (FIV)-associated lymphoma: a potential role for
the post-feline leukemia virus era, J Vet Intern Med 19:329–335, 2005. immune dysfunction in tumourigenesis, Vet Immunol Immuno-
428. Vail DM, Moore AS, Ogilvie GK, et al.: Feline lymphoma (145 pathol 65:309–322, 1998.
cases): proliferation indices, cluster of differentiation 3 immunore- 449. Callanan JJ, McCandlish IA, O’Neil B, et al.: Lymphosarcoma in
activity, and their association with prognosis in 90 cats, J Vet Intern experimentally induced feline immunodeficiency virus infection,
Med 12:349–354, 1998. Vet Rec 130:293–295, 1992.
429. S.M.C.: Feline viral neoplasia. In Greene C, editor: Infectious dis- 450. Endo Y, Cho KW, Nishigaki K, et al.: Molecular characteristics of
eases of the dog and cat, Philadelphia, 1998, WB Saunders. malignant lymphomas in cats naturally infected with feline immu-
430. Meichner K, Fogle JE, English L, et al.: Expression of apoptosis- nodeficiency virus, Vet Immunol Immunopathol 57:153–167, 1997.
regulating proteins Bcl-2 and Bax in lymph node aspirates from 451. Gabor LJ, Love DN, Malik R, et al.: Feline immunodeficiency
dogs with lymphoma, J Vet Intern Med 30:819–826, 2016. virus status of Australian cats with lymphosarcoma, Aust Vet J
431. Meichner K, von Bomhard W: Patient characteristics, histopatho- 79:540–545, 2001.
logical findings and outcome in 97 cats with extranodal subcutane- 452. Hutson CA, Rideout BA, Pedersen NC: Neoplasia associated with
ous lymphoma (2007-2011), Vet Comp Oncol 14(Suppl 1):8–20, feline immunodeficiency virus infection in cats of southern Califor-
2016. nia, J Am Vet Med Assoc 199:1357–1362, 1991.